# Tenax Therapeutics, Inc.: Form 8-K, filed Sep 16, 2025

- Company: [Tenax Therapeutics, Inc.](/companies/tenx.md) (CIK 34956)
- Form: 8-K
- Filed: 2025-09-16
- Accepted by EDGAR: Sep 16, 2025, 08:10 ET
- Period: 2025-09-16
- Accession: 0001654954-25-010792
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/34956/000165495425010792/tennx_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/34956/000165495425010792/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/34956/000165495425010792/tennx_8k.htm

Filed Sep 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001654954-25-010792. Last ingested by Listed: Nov 12, 2026, 19:31 ET. No prices; not investment advice.
